Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 14;13(12):899.
doi: 10.3390/toxins13120899.

Botulinum Toxin Therapy in Writer's Cramp and Musician's Dystonia

Affiliations
Review

Botulinum Toxin Therapy in Writer's Cramp and Musician's Dystonia

Elina Zakin et al. Toxins (Basel). .

Abstract

Task-specific focal dystonia is characterized by muscle contraction(s) during a specific task, resulting in abnormal postures or movements. Specifically, writer's cramp involves the upper extremity during the act of writing. Musician's dystonia has a highly variable presentation, and thus makes therapeutic options more limited. Treatments include oral pharmacologic agents, neuromodulation, surgery and, most often, botulinum toxin (BoNT) injection. Selection of target muscles for toxin injection continues to be an area of active research for these task-specific movements. We present a review of the literature selected from a predefined search of the MEDLINE and ClinicalTrials.gov databases. We include six controlled studies of botulinum toxin for the management of writer's cramp and focal task-specific dystonia (FTSD), including musician's dystonia. Overall, 139 patients were included across all studies, with 99 individuals injected for writer's cramp and the remaining 40 individuals with FTSD. The age range of all patients was 18-80 years old. We included studies that utilized only the BoNT-A serotype. These studies utilized various severity scales to quantify response to toxin injection, with ratings of instrument or pen control included as subjective ratings. Of the included 139 patients in this review, pooled data for toxin response show that 73% of patients who received the drug demonstrated improvement. Specific techniques for muscle localization and targeting were difficult to study as variable methods were employed. This remains an area of ongoing exploration.

Keywords: botulinum toxin; musician’s dystonia; task-specific dystonia; writer’s cramp.

PubMed Disclaimer

Conflict of interest statement

Dr. Simpson has consultancy and research funding with ALLERGAN/Abbie, Merz and Ipsen. Dr. Zakin declares no conflict of interest.

Similar articles

Cited by

References

    1. Albanese A., Bhatia K., Bressman S.B., Delong M.R., Fahn S., Fung V.S.C., Hallett M., Jankovic J., Jinnah H.A., Klein C., et al. Phenomenology and classification of dystonia: A consensus update. Mov. Disord. 2013;28:863–873. doi: 10.1002/mds.25475. - DOI - PMC - PubMed
    1. Lungu C., Ahmad O.F. Update on the use of botulinum toxin therapy for focal and task-specific dystonias. Semin. Neurol. 2016;36:41–46. - PubMed
    1. Torres-Russotto D., Perlmutter J.S. Task-specific dystonias: A review. Ann. N. Y. Acad. Sci. 2008;1142:179–199. doi: 10.1196/annals.1444.012. - DOI - PMC - PubMed
    1. Sheehy M.P., Marsden C.D. Writers’ cramp—A focal dystonia. Brain. 1982;105:461–480. doi: 10.1093/brain/105.3.461. - DOI - PubMed
    1. Goldman J.G. Writer’s cramp. Toxicon. 2015;107:98–104. doi: 10.1016/j.toxicon.2015.09.024. - DOI - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources